Clinical relevance of P-glycoprotein expression in haematological malignancies
- 30 April 1994
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 18 (4) , 233-243
- https://doi.org/10.1016/0145-2126(94)90025-6
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Chemosensitisation and drug accumulation effects of cyclosporin A, PSC-833 and verapamil in human MDR large cell lung cancer cells expressing a 190k membrane protein distinct from P-glycoproteinEuropean Journal Of Cancer, 1993
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992
- Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase π gene expression in primary and relapsed state adult and childhood leukaemiasBritish Journal of Cancer, 1992
- Various Methods of Analysis of mdr-1/P-Glycoprotein in Human Colon Cancer Cell LinesJNCI Journal of the National Cancer Institute, 1992
- Probing daunorubicin accumulation defects in non‐P‐glycoprotein expressing multidrug‐resistant cell lines using digitoninInternational Journal of Cancer, 1992
- Expression of mdr1 and mdr3 multidrug-resistance genes in hairy cell leukaemiaEuropean Journal of Cancer and Clinical Oncology, 1991
- Multidrug resistance (mdr) genes in human cancerBritish Journal of Cancer, 1991
- Expression of mdr1 and mdr3 Multidrug-resistance Genes in Human Acute and Chronic Leukemias and Association With Stimulation of Drug Accumulation by CyclosporineJNCI Journal of the National Cancer Institute, 1990
- Expression of themdr3 gene in prolymphocytic leukemia: Association with cyclosporin-a-induced increase in drug accumulationInternational Journal of Cancer, 1990
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989